Matulane Side Effects
Generic name: procarbazine
Note: This document contains side effect information about procarbazine. Some of the dosage forms listed on this page may not apply to the brand name Matulane.
Some side effects of Matulane may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to procarbazine: oral capsule
Get emergency medical help if you have any of these signs of an allergic reaction while taking procarbazine (the active ingredient contained in Matulane) hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
diarrhea that is watery;
a light-headed feeling, like you might pass out;
numbness, burning pain, or tingly feeling;
confusion, hallucinations, problems with vision or speech, trouble with walking or daily activities;
feeling unsteady, loss of balance or coordination;
tremors, seizure (convulsions);
cough, chest pain, trouble breathing;
fever, chills, body aches, flu symptoms;
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
white patches or sores inside your mouth or on your lips;
jaundice (yellowing of the skin or eyes); or
bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds.
Common side effects may include:
mild nausea, vomiting, loss of appetite, stomach pain;
dry mouth, constipation, mild diarrhea;
mild itching or rash, temporary hair loss;
muscle of joint pain;
headache, dizziness, feeling tired;
urinating more than usual; or
changes in your menstrual periods.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to procarbazine: oral capsule
Hematologic side effects are dose limiting and recovery may be delayed. Leukopenia, anemia, and thrombocytopenia have been reported to occur frequently. Pancytopenia, eosinophilia, hemolytic anemia, and bleeding tendencies including petechiae, purpura, epistaxis, hematuria and hemoptysis have also been reported.
Hematologic toxicity, common to many hydrazine derivatives, include hemolysis, eosinophilia, anisocytosis, poikilocytosis, lymphocytosis and the appearance of Heinz-Ehrlich inclusion bodies in erythrocytes.
Most of the nausea and vomiting occur with initial drug administration. In one study, 15 of 43 patients suffered severe gastrointestinal toxicity.
Gastrointestinal side effects including nausea and vomiting are the most commonly reported. Hepatic dysfunction, jaundice, stomatitis, hematemesis, melena, diarrhea, dysphagia, anorexia, abdominal pain, constipation, and dry mouth have also been reported.
Nervous system side effects including leukoencephalopathy, coma, convulsions, neuropathy, ataxia, paresthesia, nystagmus, diminished reflexes, falling, foot drop, headache, dizziness, chills, weakness, fatigue, hallucinations and unsteadiness have been reported.
In one study, peripheral neuropathy with paresthesia of the extremities and depressed deep tendon reflexes were reported to occur in 17% of patients. These effects, as well as ataxia, have been known to be reversible in some patients even as administration of the drug was continued.
Cardiovascular side effects including hypotension, tachycardia, and syncope have been reported.
Ocular side effects including retinal hemorrhage, papilledema, photophobia, diplopia and inability to focus have been reported.
Respiratory side effects including pneumonitis, pleural effusion, and cough have been reported.
Dermatologic side effects including herpes, dermatitis, pruritus, alopecia, hyperpigmentation, rash, urticaria, and flushing have been reported.
If a rash develops that is self limiting, it may be prevented during subsequent courses of therapy by administration of steroids.
In one study, 12 of 68 patients receiving procarbazine (the active ingredient contained in Matulane) experienced a hypersensitivity reaction. Other studies have reported less frequent occurrences. One study noted 2 rashes out of 24 patients and another study noted 1 rash and 1 case of urticaria out of 129 patients.
Hypersensitivity side effects have been reported.
Genitourinary side effects including hematuria, urinary frequency, and nocturia have been reported.
Musculoskeletal side effects including pain (myalgia and arthralgia) and tremors have been reported.
Psychiatric side effects including hallucinations, depression, apprehension, agitation, psychosis, nervousness, confusion, mania and nightmares have been reported.
Endocrine side effects including gynecomastia in prepuberal and early puberal boys have been reported.
Oncologic side effects with instances of a secondary nonlymphoid malignancy, including lung cancer, acute myelocytic leukemia, and malignant myelosclerosis have been reported in patients with Hodgkin's disease treated with procarbazine (the active ingredient contained in Matulane) in combination with other chemotherapy and/or radiation.
The risks of secondary lung cancer from treatment appear to be multiplied by tobacco use.
The carcinogenicity of procarbazine in mice, rats, and monkeys has been reported in a considerable number of studies.
Other side effects including azoospermia, intercurrent infections, hearing loss, pyrexia, diaphoresis, lethargy, weakness, fatigue, edema, chills, insomnia, slurred speech, hoarseness, hyperpyrexia, and drowsiness have been reported.
More Matulane resources
- Matulane Prescribing Information (FDA)
- Matulane Concise Consumer Information (Cerner Multum)
- Matulane Monograph (AHFS DI)
- Matulane MedFacts Consumer Leaflet (Wolters Kluwer)
- Matulane Advanced Consumer (Micromedex) - Includes Dosage Information
- Procarbazine Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.